Press Releases

CAMBRIDGE, Mass., Feb. 22, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc.(Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced today that the company will participate in the Citi 2012 Global Healthcare Conference in New York Cit...

Efficacy and Safety Profile MaintainedCompany to Webcast Presentation at the 30th Annual J.P. Morgan Healthcare Conference CAMBRIDGE, Mass., Jan. 6, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe l...